New York has pre-filed Senate Bill 495, which proposes legalizing medical psilocybin use under strict conditions.

Administration would occur in clinical settings or at home under certified facilitators, who must complete state-regulated training. The Department of Health will oversee research, program evaluation, and biennial reporting.

The bill includes protections for patients and facilitators and establishes a Psilocybin Assisted Therapy Advisory Board to guide implementation and public health standards.

While the bill does not list qualifying conditions for psilocybin therapy, it does note that the Advisory Board will make policy recommendations to the Department of Health, and that the Board shall be consisted of 13 members, listing what type of experts and representatives must make up the Advisory Board.

Additionally, a grant program would fund therapy for veterans, first responders, and low-income individuals.

The bill also states that The Department of Agriculture and Markets shall establish and oversee the implementation of a pilot program for psilocybin-containing mushrooms to be grown in the state.  The department shall promulgate all necessary rules and regulations, regarding medical, therapeutic, or supported use of naturally grown psilocybin mushrooms.

The bill would take effect immediately if enacted.